Patients with Chronic Pulmonary Disease Hydrocodone bitartrate and acetaminophen tablet-treated patients with significant chronic obstructive pulmonary disease or cor pulmonale, and those with a substantially decreased respiratory reserve, hypoxia, hypercapnia, or pre-existing respiratory depression are at increased risk of decreased respiratory drive including apnea, even at recommended dosages of hydrocodone bitartrate and acetaminophen tablets [see WARNINGS, Life-Threatening Respiratory Depression]
Patients should be advised to maintain adequate fluid intake, particularly during dose escalation
Numerous studies have proven that GLP-1 receptor agonists consistently lead to weight loss reducing appetite, enhancing fullness, slowing gastric emptying, and reducing food intake
But theres no hard scientific data to back that fear up yet, she cautions
The continued strength of the beverage segment reflects effective category expansion from cultural tradition into mainstream wellness positioning, supported by product innovation, flavor diversification, and strategic retail placement
Huang, Y., Fang, W., Wang, Y., Yang, W
